These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16641847)

  • 1. Premenstrual syndrome in adolescents: diagnosis and treatment.
    Rapkin AJ; Mikacich JA
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():132-7. PubMed ID: 16641847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.
    Frackiewicz EJ; Shiovitz TM
    J Am Pharm Assoc (Wash); 2001; 41(3):437-47. PubMed ID: 11372908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating premenstrual dysphoric disorder using serotonin agents.
    Lin J; Thompson DS
    J Womens Health Gend Based Med; 2001 Oct; 10(8):745-50. PubMed ID: 11703886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.
    Rapkin AJ; Mikacich JA
    Paediatr Drugs; 2013 Jun; 15(3):191-202. PubMed ID: 23529867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices.
    Mitwally MF; Kahn LS; Halbreich U
    Expert Opin Pharmacother; 2002 Nov; 3(11):1577-90. PubMed ID: 12437492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.
    Parry BL
    CNS Drugs; 2001; 15(4):277-85. PubMed ID: 11463133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Brown J; O' Brien PM; Marjoribanks J; Wyatt K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premenstrual syndrome.
    Yonkers KA; O'Brien PM; Eriksson E
    Lancet; 2008 Apr; 371(9619):1200-10. PubMed ID: 18395582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Rapkin AJ; Mikacich JA
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):455-63. PubMed ID: 18797268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.
    Steiner M
    J Psychiatry Neurosci; 2000 Nov; 25(5):459-68. PubMed ID: 11109297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PMS and PMDD].
    Leminen H; Paavonen J
    Duodecim; 2013; 129(17):1756-63. PubMed ID: 24159708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of premenstrual disorders.
    Kroll R; Rapkin AJ
    J Reprod Med; 2006 Apr; 51(4 Suppl):359-70. PubMed ID: 16734319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder.
    Rapkin A
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():39-53. PubMed ID: 12892989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches].
    Lenzinger E; Diamant K; Vytiska-Binstorfer E; Kasper S
    Nervenarzt; 1997 Sep; 68(9):708-18. PubMed ID: 9411273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of premenstrual dysphoric disorder.
    Rapkin AJ; Lewis EI
    Womens Health (Lond); 2013 Nov; 9(6):537-56. PubMed ID: 24161307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Wyatt KM; Dimmock PW; O'Brien PM
    Cochrane Database Syst Rev; 2002; (4):CD001396. PubMed ID: 12519554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.
    Steiner M; Pearlstein T; Cohen LS; Endicott J; Kornstein SG; Roberts C; Roberts DL; Yonkers K
    J Womens Health (Larchmt); 2006; 15(1):57-69. PubMed ID: 16417420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.